Stockscreener 앱 받기
2.69
2.89%
-0.08
시간 외 거래:
2.72
0.03
+1.12%
Aclarion Inc 주식(ACON)의 최신 뉴스
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site - orthospinenews.com
Aclarion adds University of Arizona to Nociscan spine trial - Investing.com
Aclarion Announces Addition of University of Arizona College of MedicinePhoenix as CLARITY Trial Site - The Manila Times
Aclarion's 300-patient back-pain study now has 10 enrolling sites - Stock Titan
Aclarion (ACON) EPS and Revenue: The Available Earnings Metric Delivers a Miss in Latest Trading; After Results: The Stock Gains 6.54% on the DayROIC Trend Report - Vinanet
Aclarion director Amanda Williams buys $15,989 in common stock By Investing.com - Investing.com Nigeria
Aclarion director Amanda Williams buys $15,989 in common stock - Investing.com
Top Aclarion Executive Makes Bold Insider Move on Company Stock - TipRanks
Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock By Investing.com - Investing.com Nigeria
Aclarion (ACON) Earnings Numbers in Focus: EPS Comes in Below Forecast under the Current Snapshot; Investor Response: The Market Price Declines 6.14% on the DayHealthcare Earnings Report - Vinanet
ACON | Aclarion, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock - Investing.com
Major Insider Buying Spree Signals Strong Confidence in This Tech Stock - TipRanks
Aclarion director David K. Neal buys $18,000 in common stock By Investing.com - Investing.com Nigeria
Aclarion director David K. Neal buys $18,000 in common stock - Investing.com
Aclarion CEO Brent Ness buys $12,090 in company stock By Investing.com - Investing.com India
Aclarion director William Wesemann buys $5,031 in company stock - Investing.com
Aclarion director Ryan Bond buys $50,059 in ACON shares - Investing.com
Aclarion Inc. Warrant (ACONW) Jumps 21.95% to $0.03 as Support and Resistance ConvergeNarrow Range Breakout - dars.gov.et
Aclarion receives patent allowance for MRI scan technology By Investing.com - Investing.com Nigeria
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process - The Manila Times
Aclarion Receives USPTO Notice of Allowance for Patent Covering Multi-Voxel Prescription for Lumbar Disc Evaluation - Quiver Quantitative
Aclarion receives patent allowance for MRI scan technology - Investing.com
Aclarion Receives Notice Of Allowance For Patent Advancing Accuracy And Adoption Of Nociscan's MR Spectroscopy Scan Process - marketscreener.com
Aclarion says USPTO issues notice of allowance for lumbar disc MRS scan-prescription patent application - Bitget
Aclarion Inc. (ACON) Slips 3.39% as Shares Approach Key $2.17 SupportTake Profit Levels - Vinanet
Aclarion, Inc. Revenue Breakdown – FWB:IT20 - TradingView
Aclarion, Inc. Revenue Breakdown – BOATS:ACONW - TradingView
Aclarion Inc (ACON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Aclarion, Inc. Q2 2026: Revenue $25.2K, EPS $(1.12) — 10-Q Summary - TradingView
Aclarion (NASDAQ: ACON) posts $5.6M H1 loss, holds $16.3M cash - Stock Titan
Tranche Update on Aclarion, Inc.'s Equity Buyback Plan announced on April 22, 2026. - marketscreener.com
Aclarion Q2 FY26 net loss narrows 59.27% to $2.75 million; revenue rises 30.5% to $25,208 - Bitget
Aclarion Inc. Warrant (ACONW) Slips 2.39% but Remains Supported at $0.02Resistance Breakout Stocks - dars.gov.et
Aclarion (ACON) Slips 1.69% to $2.32: Stock Presses Against Support at $2.20Strong Buy Stocks - dars.gov.et
Aclarion’s Nociscan Expands to Goodman Campbell Brain & Spine in First Indiana Site - Quiver Quantitative
Aclarion, Inc Announces Nociscan Now Available At Goodman Campbell Brain & Spine At Ascension St. Vincent - marketscreener.com
Aclarion Inc. Warrant (ACONW) Surges 35% to $0.03, Trading at Critical JunctureETF Inflow Streak - dars.gov.et
Aclarion Inc. Warrant (ACONW) Holds at $0.02 as Trading Range Compresses to a PointFibonacci Retracement - dars.gov.et
Aclarion Inc. Warrant (ACONW) Holds Steady at $0.02 as Trading Range CompressesReversal Trade - Vinanet
ACON Q1 2026 Earnings: EPS Exceeds Estimates by 15.2%, Shares Rise 11.4%Earnings Deceleration Risk - Vinanet
Aclarion Inc. Warrant (ACONW) Flat at $0.02 as Support and Resistance ConvergePrice Target - Vinanet
Aclarion reports 141% scan volume growth in first half of 2026 - Investing.com Nigeria
Aclarion Inc. (ACON) Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift SentimentPost-Announcement Reaction - Vinanet
Aclarion, Inc. Revenue Breakdown – BOATS:ACON - TradingView
Aclarion Inc (ACON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aclarion Inc (ACON) Institutional Confidence - TradingKey
Aclarion Inc (ACON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aclarion Inc (ACON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aclarion Inc (ACON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aclarion Inc (ACON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ACON|Aclarion Inc|Price:2.420|Chg%:-0.030 - TradingKey
Aclarion Market Sentiment - Benzinga España
ACON|Aclarion Inc|Price:2.420|Chg%:+0.020 - TradingKey
TradingKey - TradingKey
Aclarion, Inc. Revenue Breakdown – TRADEGATE:IT20 - TradingView
Aclarion, Inc. Revenue Breakdown – NASDAQ:ACONW - TradingView
ACON Q1 2026 Earnings: EPS Surprises to the Upside Amid No Reported RevenueDownward Estimate Revision - Vinanet
Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice - orthospinenews.com
Aclarion Nociscan Case Reports 95% Relief Without Classic MRI Signs - Stock Titan
Aclarion Inc. Warrant (ACONW) Slips to $0.02 as Penny Stock Volatility PersistsChannel Breakout - Vinanet
ACON Q1 2026 Earnings: Narrower Loss Beats Expectations, Stock RisesRetail Earnings Report - po-news-eg.net
Aclarion, Inc. Warrant 2022- on Aclarion Financial Disclosures & SEC Filings - TradingView
Aclarion Inc. (ACON) Q1 2026 Earnings: EPS Beat Estimates Despite No Reported RevenueEarnings Beat Alert - dars.gov.et
Return on equity % of Aclarion, Inc. – TRADEGATE:IT20 - TradingView
Aclarion Inc. (ACON) Faces Modest Decline as Stock Hovers Near Support LevelBollinger Squeeze - Vinanet
1.35%
2.79%
자본화:
|
볼륨(24시간):